About this trial
From the archives of the Rizzoli institute all the patients (approximately 150 patients) undergoing oncological reconstruction of proximal femur from 01/01/1991 to 31/12/2023.
A review will be made from the medical records, radiological imaging, and histological data of these patients
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Male and female patients surgically treated with an oncological reconstruction of the proximal femur at Rizzoli Orthopaedic Institute between 01/01/1991 and 31/12/2023
Age: 18-90 years old (at the time of primary surgery)
Diagnosis of bone sarcoma
Patients with available clinical and imaging data
Disqualifiers
At least one inclusion criterion not met
Trial population
Male and female patients surgically treated with an oncological reconstruction of the proximal femur at Rizzoli Orthopaedic Institute between 01/01/1991 and 31/12/2023
Trial design
Cohort
Retrospective
Treatments tested in this trial
Analysis
Other interventionAnalysis and review of imaging and clinical data
Treatment groups
Trial outcomes
Primary outcomes
longevity of the reconstruction
evaluation of the longevity of the reconstruction, meaning reconstruction failure-free survival after surgery
Secondary outcomes
Musculoskeletal tumour society (MSTS) functional evaluation
The MSTS questionnaire consists of six domains, each scored on a scale from 0 to 5, with a higher score indicating better function.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Costantino Errani
Lead sponsor
Istituto Ortopedico Rizzoli
Sponsor institution